Background
Dr. Amanda W. Pong graduated magna cum laude from Columbia University, completed medical school at University of Pittsburgh and pediatrics training at the University of California at San Diego. Dr. Pong pursued her neurology training at Harvard Medical School's Boston Children's, Massachusetts General, Brigham and Women's and Beth Israel Deaconess Hospitals. She served as Chief Resident and completed a fellowship in Epilepsy and Clinical Neurophysiology at Boston Children's Hospital, Harvard Medical School.
Dr. Pong was recruited to the Columbia Comprehensive Epilepsy Center where she managed complex pediatric epilepsy patients and the 6-bed epilepsy monitoring unit and the pediatric epilepsy ICU consultation service. Her academic work centered on novel therapies, genetic evaluation of the epilepsies, and rare genetic epilepsies, including the elucidation of epilepsy phenotypes in GLUT-1 Deficiency. She holds a Masters in Biostatistics for Patient Oriented Research from the Mailman School of Public Health at Columbia University. ​
Currently, Dr. Pong is the Director of Pediatric Epilepsy at the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, Maryland, which is a unique, independent, academically oriented, clinical and research center. The center is directed by Dr. Pavel Klein, a renowned leader in development of new treatments for epilepsy in adults. Here, Dr. Pong has grown a thriving pediatric epilepsy practice with on-site EEG, genetic testing, and lab services. She continues to work with rare and genetic epilepsy via rare condition foundation collaborations, clinical trial work and leading symposia on research and new treatments. She has founded specialty clinics for Lennox-Gastaut Syndrome, Dravet Syndrome and Tuberous Sclerosis Complex. She is particularly active in uncovering new treatments for drug refractory epilepsy, understanding issues of drug safety and the possiblity of epilepsy prevention.